A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis

Pediatric Pulmonology

Volumn 47, Issue 3, 2012, Pages 252-263

  Stalvey, Michael S ^a   Anbar, Ran D ^b   Konstan, Michael W ^c   Jacobs, Joan R ^d   Bakker, Bert ^d   Lippe, Barbara ^d   Geller, David E ^e  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GENENTECH INC   (United States)

^e NEMOURS CHILDREN S HOSPITAL   (United States)

Author keywords

body composition; efficacy; growth; pulmonary function; safety

Indexed keywords

HUMAN GROWTH HORMONE;

ADOLESCENT; ARTICLE; CHILD; CHILD GROWTH; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES MELLITUS; DIABETES MELLITUS; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLUCOSE TOLERANCE; GROWTH DISORDER; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INJECTION SITE REACTION; INTRACRANIAL HYPERTENSION; LEAN BODY WEIGHT; LUNG DISEASE; LUNG FUNCTION; MALE; MULTICENTER STUDY; OPEN STUDY; PAPILLEDEMA; PHASE 2 CLINICAL TRIAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; WALKING;

ADOLESCENT; BODY COMPOSITION; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN GROWTH HORMONE; HUMANS; LUNG; MALE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 84857370463     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21546     Document Type: Article

References (42)

1. Davis PB,. Cystic fibrosis since 1938. Am J Respir Crit Care Med 2006; 173: 475-482.
2. Cystic Fibrosis Foundation Patient Registry, 2008 Annual Data Report. Bethesda, Maryland; 2009.
3. Hardin DS,. A review of the management of two common clinical problems found in patients with cystic fibrosis: cystic fibrosis-related diabetes and poor growth. Horm Res 2007; 68: 113-1116.
4. Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta C, Colombo C,. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 2006; 21: 388-396.
5. Beker LT, Russek-Cohen E, Fink RJ,. Stature as a prognostic factor in cystic fibrosis survival. J Am Diet Assoc 2001; 101: 438-442. (Pubitemid 33712127)
6. Konstan MW, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ,. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 2003; 142: 624-630. (Pubitemid 36737164)
7. Sharma R, Florea VG, Bolger AP, Doehner W, Florea ND, Coats AJ, Hodson ME, Anker SD, Henein MY,. Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 2001; 56: 746-750. (Pubitemid 32917542)
8. Hardin DS, LeBlanc A, Lukenbaugh S, Para L, Seilheimer DK,. Proteolysis associated with insulin resistance in cystic fibrosis. Pediatrics 1998; 101: 433-437. (Pubitemid 28136419)
9. Chinuck RS, Fortnum H, Baldwin DR,. Appetite stimulants in cystic fibrosis: a systematic review. J Hum Nutr Diet 2007; 20: 526-537. (Pubitemid 350142234)
10. Veldhuis JD, Roemmich JN, Richmond EJ, Rogol AD, Lovejoy JC, Sheffield-Moore M, Mauras N, Bowers CY,. Endocrine control of body composition in infancy, childhood, and puberty. Endocr Rev 2005; 26: 114-146. (Pubitemid 40209389)
11. Sood M, Adams JE, Mughal MZ,. Lean body mass in children with cystic fibrosis. Arch Dis Child 2003; 88: 836. (Pubitemid 37094248)
12. Enright S, Chatham K, Ionescu AA, Unnithan VB, Shale DJ,. The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis. J Cyst Fibros 2007; 6: 384-390. (Pubitemid 350047393)
13. Ionescu AA, Evans WD, Pettit RJ, Nixon LS, Stone MD, Shale DJ,. Hidden depletion of fat-free mass and bone mineral density in adults with cystic fibrosis. Chest 2003; 124: 2220-2228. (Pubitemid 38010593)
14. Pedreira CC, Robert RG, Dalton V, Oliver MR, Carlin JB, Robinson P, Cameron FJ,. Association of body composition and lung function in children with cystic fibrosis. Pediatr Pulmonol 2005; 39: 276-280. (Pubitemid 40460698)
15. Franklin SL, Geffner ME,. Growth hormone: the expansion of available products and indications. Endocrinol Metab Clin North Am 2009; 38: 587-611.
16. Hardin DS, Ellis KJ, Dyson M, Rice J, McConnell R, Seilheimer DK,. Growth hormone decreases protein catabolism in children with cystic fibrosis. J Clin Endocrinol Metab 2001; 86: 4424-4428. (Pubitemid 32848569)
17. Hardin DS, Ellis KJ, Dyson M, Rice J, McConnell R, Seilheimer DK,. Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial. J Pediatr 2001; 139: 636-642. (Pubitemid 33097426)
18. Schibler A, von der Heiden R, Birrer P, Mullis PE,. Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis. Arch Dis Child 2003; 88: 1078-1081. (Pubitemid 38064483)
19. Schnabel D, Grasemann C, Staab D, Wollmann H, Ratjen F,. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis. Pediatrics 2007; 119: e1230-e1238. (Pubitemid 46871239)
20. Alemzadeh R, Upchurch L, McCarthy V,. Anabolic effects of growth hormone treatment in young children with cystic fibrosis. J Am Coll Nutr 1998; 17: 419-424. (Pubitemid 28445330)
21. Phung OJ, Coleman CI, Baker EL, Scholle JM, Girotto JE, Makanji SS, Chen WT, Talati R, Kluger J, White CM,. Recombinant human growth hormone in the treatment of patients with cystic fibrosis. Pediatrics 2010; 126: e1211-e1226.
22. Greulich W, Pyle S,. Radiographic atlas of skeletal development of the hand and wrist, 2nd edition. Stanford, California: Stanford University Press; 1959.
23. Borowitz D, Baker RD, Stallings V,. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002; 35: 246-259.
24. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Curtin LR, Roche AF, Johnson CL,. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 2002; 11: 1-190.
25. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG Jr., Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993; 15: 75-88.
26. Atabek ME, Pirgon O,. Assessment of insulin sensitivity from measurements in fasting state and during an oral glucose tolerance test in obese children. J Pediatr Endocrinol Metab 2007; 20: 187-195. (Pubitemid 46865069)
27. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Borowitz D, Brunzell C, Campbell PW III, Chesrown SE, Duchow C, Fink RJ, Fitzsimmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Madhun Z, Pencharz PB, Quittner AL, Robbins MK, Schindler T, Schissel K, Schwarzenberg SJ, Stallings VA, Zipf WB,. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus: a consensus conference report. Diabetes Res Clin Pract 1999; 45: 61-73. (Pubitemid 29356125)
28. Hochberg Y,. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988; 75: 800-802.
29. Magoffin A, Allen JR, McCauley J, Gruca MA, Peat J, Van Asperen P, Gaskin K,. Longitudinal analysis of resting energy expenditure in patients with cystic fibrosis. J Pediatr 2008; 152: 703-708.
30. Powers SW, Patton SR, Byars KC, Mitchell MJ, Jelalian E, Mulvihill MM, Hovell MF, Stark LJ,. Caloric intake and eating behavior in infants and toddlers with cystic fibrosis. Pediatrics 2002; 109: E75-5.
31. Huseman CA, Colombo JL, Brooks MA, Smay JR, Greger NG, Sammut PH, Bier DM,. Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients. Pediatr Pulmonol 1996; 22: 90-95. (Pubitemid 26295879)
32. Darmaun D, Hayes V, Schaeffer D, Welch S, Mauras N,. Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis. J Clin Endocrinol Metab 2004; 89: 1146-1152. (Pubitemid 38368403)
33. Hardin DS, Adams-Huet B, Brown D, Chatfield B, Dyson M, Ferkol T, Howenstine M, Prestidge C, Royce F, Rice J, Seilheimer DK, Steelman J, Shepherds R,. Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial. J Clin Endocrinol Metab 2006; 91: 4925-4929. (Pubitemid 44917328)
34. Laron Z, Klinger B, Anin S, Pertzelan A, Lilos P,. Growth during and 2 years after stopping GH treatment in prepubertal children with idiopathic short stature. J Pediatr Endocrinol Metab 1997; 10: 191-196. (Pubitemid 27223666)
35. Fjellestad-Paulsen A, Simon D, Czernichow P,. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment. J Clin Endocrinol Metab 2004; 89: 1234-1239. (Pubitemid 38368419)
36. Bray GA,. Afferent signals regulating food intake. Proc Nutr Soc 2000; 59: 373-384.
37. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H,. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008; 108: 832-839. (Pubitemid 351602057)
38. Peterson ML, Jacobs DR Jr, Milla CE,. Longitudinal changes in growth parameters are correlated with changes in pulmonary function in children with cystic fibrosis. Pediatrics 2003; 112: 588-592. (Pubitemid 37082112)
39. Assael BM, Casazza G, Iansa P, Volpi S, Milani S,. Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening. Pediatr Pulmonol 2009; 44: 209-215.
40. Jorgensen JO, Krag M, Jessen N, Norrelund H, Vestergaard ET, Moller N, Christiansen JS,. Growth hormone and glucose homeostasis. Horm Res 2004; 62: 51-55.
41. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B,. CFRD Guidelines Committee. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010; 33: 2697-2708.
42. Frohnert BI, Ode KL, Moran A, Nathan BM, Laguna T, Holme B, Thomas W,. Impaired fasting glucose in cystic fibrosis. Diabetes Care 2010; 33: 2660-2664.